Very proud to be part of the IV International Thoracic Cancer Debates in Gran Canaria with an exciting and engaging agenda on lung cancer with global experts. Great program crafted by Drs. Delvys Rodriguez Abreu Luis Paz-Ares charocampelo - follow along #ITCD2026!

Lively discussion on neoadjuvant targeted therapy and other controversies in early stage at #ITCD2026 with Drs. Dr. Luis E. Raez Pilar Garrido Dr. Antonio Calles 🫁🚭 Margarita Majem Edgardo Santos, MD, FACP, FASCO Lorenza Landi Enric Carcereny Ernest Nadal Narjust Florez, MD, FASCO

Dr. Pasi Janne at #ITCD2026 details resistance to EGFR NSCLC. Acquired resistance is impacted by choice of initial therapy and should guide subsequent therapy. Excited about some of the new emerging compounds including novel EGFR inhibitors.

Fourth annual #ITCD2026 meeting in Gran Canaria. Grateful to my scientific co-chairs Delvys Rodriguez Abreu Luis Paz-Ares charocampelo and close friends that joined to debate current best practice and future priorities Giannis Mountzios Noemi Reguart Martin Reck Cecilia Pompili MD PhD FACS Solange Peters

Dr. Noemi Reguart overviews EGFR Exon 20 NSCLC at #ITCD2026. Heterogeneous group and treatment choice has to be guided by unique biology. Amivantamab a mainstay now and excited about subcutaneous option and emerging TKIs will complement the field.

At #ITCD2026 discussing today MRD in #lungcancer thanks to Stephen V Liu, MD Delvys Rodriguez Abreu Rosario Campelo for the invitation. Edgardo Santos, MD, FACP, FASCO Dr. Antonio Calles 🫁🚭 charocampelo Marina Garassino Cecilia Pompili MD PhD FACS

KRAS inhibition in Non Small Cell Cancer comprehensive review by Jordi Remon at #ITCD2026 #lcsm OncoAlert

New 1st line ongoing trials for KRAS inhibition in Non Small Cell Cancer comprehensive review by Jordi Remon at #ITCD2026 #lcsm OncoAlert

Thank you for the invitation and the intellectual freedom! #ITCD2026

Great first day at #ITCD2026 Walks and walks and the hunt for Starbucks with Jess

Amazing advances in ROS1 and RET NSCLC outlined by Dr. JessicaJLinMD at #ITCD2026. For ROS1, taletrectinib offers impressive efficacy. Will zidesamtinib build on that progress? Still learning about resistance to next gen TKIs. For RET, selpercatinib and pralsetinib still SOC.

Dr. Enriqueta Felip at #ITCD2026 discusses METex14 in NSCLC. While chemoIO is active, states case to start with TKIs like capmatinib or tepotinib first. For NTRK, larotrectinib and entrectinib recently joined by repotrectinib.

Such an amazing meeting! Loving the scientific exchange at #ITCD2026. Proud to be part of this community!

Fantastic discussion at #ITD2026 with Dr @NarjustFlorez on neoadjuvant approaches with targeted therapy. Really inspiring discussion around surgical considerations and different perspectives on NeoAdaura data. #ITCD2026

Strong discussion on small cell lung cancer today at #ITCD2026. Great panel, sharp insights, and meaningful debate on where SCLC management is heading.

Fantastic session and panel on #SCLC to kick off day 2 of #ITCD2026 with Stephen V Liu, MD Helena Linardou Giannis Mountzios Great initial insights from surgical resection in Irish SCLC cases, presented by Jarushka Naidoo Really thought-provoking discussion

Dr. Marina Garassino breaks down TROP2 ADCs at #ITCD2026, comparing and contrasting competing agents. Impressive outcomes in EGFR+ but will the future be broader? NMR as an emerging biomarkers?

#ITCD2026 Great to be a part of this superb session on #SCLC with leading voices Stephen V Liu, MD & Giannis Mountzios Thanks to #KateCoakley & David O Reilly for helping to examine our 🇮🇪 data on stage I SCLC- an open question in LS SCLC! OncoAlert ESMO - Eur. Oncology Beaumont RCSI Cancer Centre #LCSM

#ITCD2026 faculty and conference dinners were a fantastic opportunity to continue the discussions outside of the conference hall - to network, to brainstorm, and to connect with friends from around the world

Fantastic talks and a great discussion on SCLC at the #ITCD2026. Thank you Giannis Mountzios Helena Linardou Stephen V Liu, MD Jarushka Naidoo for sharing your expertise.